The effects of canagliflozin in type 2 diabetes in subgroups defined by population-specific body mass index: Insights from the CANVAS Program and CREDENCE trial
Jie Yu*, Arianne N. Sweeting, Chris Gianacas, Lauren Houston, Vivian Lee, Robert A. Fletcher, Vlado Perkovic, Qiang Li, Brendon L. Neuen, Otavio Berwanger, Hiddo J.L. Heerspink, Dick de Zeeuw, Clare Arnott
Research output: Contribution to journal › Article › Academic › peer-review
3Citations
(Scopus)
42Downloads
(Pure)
Fingerprint
Dive into the research topics of 'The effects of canagliflozin in type 2 diabetes in subgroups defined by population-specific body mass index: Insights from the CANVAS Program and CREDENCE trial'. Together they form a unique fingerprint.